130 related articles for article (PubMed ID: 10743969)
1. Nitric oxide inhibits aggrecan degradation in explant cultures of equine articular cartilage.
Bird JL; May S; Bayliss MT
Equine Vet J; 2000 Mar; 32(2):133-9. PubMed ID: 10743969
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.
Sztrolovics R; White RJ; Roughley PJ; Mort JS
Biochem J; 2002 Mar; 362(Pt 2):465-72. PubMed ID: 11853556
[TBL] [Abstract][Full Text] [Related]
4. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
[TBL] [Abstract][Full Text] [Related]
5. IL-1 beta induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide.
Bird JL; Wells T; Platt D; Bayliss MT
Biochem Biophys Res Commun; 1997 Sep; 238(1):81-5. PubMed ID: 9299456
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
7. Exercise-induced changes in proteoglycan metabolism of equine articular cartilage.
Bird JL; Platt D; Wells T; May SA; Bayliss MT
Equine Vet J; 2000 Mar; 32(2):161-3. PubMed ID: 10743973
[No Abstract] [Full Text] [Related]
8. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
[TBL] [Abstract][Full Text] [Related]
9. Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Arthritis Rheum; 2000 Oct; 43(10):2211-8. PubMed ID: 11037880
[TBL] [Abstract][Full Text] [Related]
10. Ageing of equine articular cartilage: structure and composition of aggrecan and decorin.
Platt D; Bird JL; Bayliss MT
Equine Vet J; 1998 Jan; 30(1):43-52. PubMed ID: 9458398
[TBL] [Abstract][Full Text] [Related]
11. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
12. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage.
Loulakis P; Shrikhande A; Davis G; Maniglia CA
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):589-93. PubMed ID: 1599440
[TBL] [Abstract][Full Text] [Related]
13. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
Chockalingam PS; Zeng W; Morris EA; Flannery CR
Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
[TBL] [Abstract][Full Text] [Related]
14. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis.
Singer II; Scott S; Kawka DW; Bayne EK; Weidner JR; Williams HR; Mumford RA; Lark MW; McDonnell J; Christen AJ; Moore VL; Mudgett JS; Visco DM
Osteoarthritis Cartilage; 1997 Nov; 5(6):407-18. PubMed ID: 9536289
[TBL] [Abstract][Full Text] [Related]
15. "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay.
Buttle DJ; Fowles A; Ilic MZ; Handley CJ
Mol Pathol; 1997 Jun; 50(3):153-9. PubMed ID: 9292151
[TBL] [Abstract][Full Text] [Related]
16. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.
Sandy JD; Gamett D; Thompson V; Verscharen C
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):59-66. PubMed ID: 9742213
[TBL] [Abstract][Full Text] [Related]
17. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration.
Little CB; Flannery CR; Hughes CE; Goodship A; Caterson B
Osteoarthritis Cartilage; 2005 Feb; 13(2):162-70. PubMed ID: 15694578
[TBL] [Abstract][Full Text] [Related]
18. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
19. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.
Lundberg C; Asberg I; Ionescu M; Reiner A; Smedegård G; Poole AR
Ann Rheum Dis; 1996 Aug; 55(8):525-34. PubMed ID: 8774180
[TBL] [Abstract][Full Text] [Related]
20. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
